Natural Products
Catalog No. | Information |
CFN95344 | 4'-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside) Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities. |
CFN95343 | New compound 10 |
CFN95342 | New compound 9 |
CFN95341 | New compound 8 |
CFN95340 | Deoxy euphorbia factor L1 Deoxy euphorbia factor L1 inhibits the growth of lung cancer A549 cells through the mitochondrial pathway (IC50 value of 17.51 ± 0.85 μM) and induces apoptosis. |
CFN95339 | Euphorbia factor L25 Reference standards. Euphorbia factor L1 analogue. |
CFN95338 | Euphorbia factor L22 Reference standards. Euphorbia factor L1 analogue. |
CFN95337 | Fuzitine |
CFN95336 | Peiioside B |
CFN95335 | 9,11-Dehydro-beta-boswellic acid 9,11-Dehydro-β-boswellic acid has urease inhibitory activity. 9,11-Dehydro-beta-boswellic acid inhibiting the key enzyme of leukotriene biosynthesis, 5-lipoxygenase (5-LO). |
CFN95334 | Euphorbia factor L24 Reference standards. Euphorbia factor L1 analogue. |
CFN95333 | Diosniposide B |
CFN95332 | Notoginsenoside L13 Reference standards |
CFN95331 | Gynosaponin TN2 Gynosaponin TN-2 has anti-Parkinsonian activity. Gynosaponin TN-2 exerts protective effects on L-DOPA (100 and 200 μM)-induced apoptotic cell death by modulating extracellular signal-regulated protein kinases 1 and 2 activation in pheochromocytoma 12 cells. |
CFN91712 | Tubuloside B Tubuloside B has the neuroprotective capacity to antagonize TNFalpha-induced apoptosis in SH-SY5Y cells and may be useful in treating some neurodegenerative diseases. Tubuloside B possesses antioxidative effects. Tubuloside B may be applied as an antiparkinsonian agent. |
CFN95330 | New compound 7 |
CFN95329 | Physalin X Physalin X exhibited inhibitory activities on NO production with IC50 values of 68.50μM. |
CFN95328 | Isophysalin G Reference standards. Physalin G analogue. |
CFN95327 | Arvenin III |
CFN95326 | Isocucurbitacin D Isocucurbitacin D showed a cytotoxic effect with disruption of target protein cofilin. Isocucurbitacin D exhibited the highest activities of improved the LDL uptake rate.Isocucurbitacin D dose-dependently increased LDLR protein levels and decreased PCSK9 protein levels. |
CFN95325 | Lathyranoic acid A |
CFN95324 | Parishin G |
CFN95323 | Cuscutamine Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation |
CFN95322 | alpha-Costic acid α-Costic acid, a plant sesquiterpene with acaricidal activity against Varroa destructor. Alpha-Costic acid is a potential biocide against two fungal strains, Penicillium roqueforti and Aspergillus niger. α-costic acid had a suppressive effect on the dodder seed germination but had a stimulating action on the broomrape seed germination. |
CFN95321 | (3beta,22alpha)-26-(beta-glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl 2-O-(6-deoxy-alpha-mannopyranosyl)-beta-glucopyranosiduronic acid Anemarsaponin E analogue. Reference standards. |
CFN95320 | Batatasin V Batatasin V has the effect of inhibiting plant growth. |
CFN95319 | Batatasin IV Batatasin IV is an LTA4H inhibitor with anti-inflammatory activity. Batatasin IV can be used in research in the area of inflammation. IC50 & Target:LTA4H |
CFN91792 | Licraside Licraside(licuraside) has potency and ability to inhibit mushroom tyrosinase monophenolase activity with an IC(50) value of 0.072 mM. Licraside(Licurazid) has anticancer properties. |
CFN91782 | (3beta,7beta,12beta,20Z)- 3,7,12- trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid, a lanostane triterpenoids, exhibits obvious NO inhibitory activity on n LPS-induced BV-2 microglia cells with an IC50 of 9.55 uM. (3β,7β,12β,20Z)-3,7,12-Trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid has anti-inflammatory activities. |
CFN91763 | (5alpha)-11-dioxo-7,15-dihydroxy-4,4,14-trimethyl-3-Chol-8-en-24-oic acid (5alpha)-11-dioxo-7,15-dihydroxy-4,4,14-trimethyl-3-Chol-8-en-24-oic acid is one of the ganoderma triterpenoids which have been recognised as an important bioactive ingredient in Ganoderma Lucidum Karst. (5alpha)-11-dioxo-7,15-dihydroxy-4,4,14-trimethyl-3-Chol-8-en-24-oic acid can be used for the research of various etiologies. |
CFN91762 | Quercetin 3-O-malonylglucoside Quercetin 3-O-malonylglucoside, a natural flavonol glycoside, possesses antioxidant activity. |
CFN95318 | Menisperine Anti-inflammatory effects (potential NF-κB inhibitors). |
CFN95317 | 4,7-Didehydroneophysalin B 4,7-Didehydroneophysalin B is a flavonoid with cholinesterase inhibiting activity. |
CFN95316 | 3',5-Dihydroxy-4',6,7-trimethoxyflavanone 3′,5-Dihydroxy-4′,6,7-trimethoxyflavanone has potent cytotoxic activity against A549 and HepG-2 cell lines. |
CFN95315 | Fortunellin-6''-beta-D-glucopyranoside (Acacetin-7-O-[2''-O-rhamnosyl-6''-O-glucosyl]-glucoside) Reference standards. |
CFN95314 | Isovitexin-2''-O-rhamnoside (2''-O-alpha-L-Rhamnopyranosyl-isovitexin) Isovitexin 2′′-O-rhamnoside, a phenolic, has antioxidant and antiproliferative activities. |
CFN95313 | Beta-Dimorphecolic acid (9(S)-HODE) Anti-inflammatory activity. |
CFN95312 | Solafuranone Solafuranone possess cytotoxic activity against human cancer cell lines at concentrations up to 30 μM. Anti-inflammatory. |
CFN95311 | Diosmin Impurity 5 Diosmin analog. Reference standards. |
CFN95310 | (R)-5,3'-Dimethyl hesperidin Hesperidin analog. Reference standards. |
CFN95309 | Diosmin Impurity 8 Diosmin analog. Reference standards. |
CFN95308 | 8'-O-(3-hydroxy-3-methylglutaryl)-8'-hydroxyabscisic acid |
CFN95307 | 13(S)-Hydroxyoctadeca-9(Z),11(E)-dienoic acid (13-HODE) Anti-inflammatory. 13-HODE down-regulates the thrombogenecity of the injured vessel wall surface. 13-HODE prevents cell adhesion to endothelial cells and can inhibit cancer metastasis. |
CFN95306 | Phloretin 3',5'-Di-C-glucoside Phloretin 3',5'-Di-C-glucoside is able to inhibit growth of Gram positive bacteria. |
CFN95305 | 11-Oxomogroside IIA2 Reference standards. |
CFN95304 | Isomargaritene Antioxidant activity. |
CFN95303 | Margaritene Margaritene, isomargaritene, and fortunellin could reduce lipid content by inhibiting adipogenesis. Antioxidants. |
CFN95302 | Clemomandshuricoside B Reference standards. |
CFN95301 | 9-Octadecenedioic acid |
CFN95300 | Glaucoside C Anticancer. Glaucoside C was evaluated against the HT-29 and HCT 116 human colon cancer cell lines. |